Fred Lublin, MD
img_Fred Lublin
PROFESSOR | Neurology
Are you a patient?
Specialties
Neurology
Neuroimmunology
Basic and translational neuroimmunology
Multiple Sclerosis
Clinical trials in MS and other demyelination disorders

MD, Thomas Jefferson University

Internship, Internal Medicine, Albert Einstein College of Medicine-Yeshiva University

Residency, Neurology, Weill Medical College of Cornell University

Certifications

American Board of Psychiatry and Neurology

2019

Award for Recognition of Leadership and Dedication in Applying Medical Education to Improve Care of Patients with Multiple Sclerosis

AcademicCME, Advanced Curriculum for Multiple Sclerosis

2019

June Halpern Lifetime Achievement Award

Consortium of Multiple Sclerosis Centers

2019

Presidential Lecture

Consortium of Multiple Sclerosis Centers

2017

Clifford Goldsmith Award

Icahn School of Medicine at Mount Sinai

2017

Honorary Member of the French Society of Neurology

Societe Francaise de Neurologie

2013

Award of Appreciation for Outstanding Academic Teaching

Icahn School of Medicine at Mount Sinai

2001

Attending of the Year Award

Mount Sinai Medical Center Neurology Residents

2000

Chairman, Research Programs Advisory Committee

National Multiple Sclerosis Society

1999

McEwan Visiting Professorship & Lecture in Neurology

University of Toronto

1999

Hope Award

National Multiple Sclerosis Society, Delaware Valley Chapter

1996

Milestone Award

National Multiple Sclerosis Society, Delaware Valley Chapter

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Lublin during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Immunic
  • Viatris
  • Ryan Ryan DeLuca Attorneys
  • Novartis Pharmaceutical Corporation
  • Franklin Casualty
  • Gibson Dunn
  • LAPIX Therapeutics, Inc.
  • Greebenrg Traurig Law Firm
  • DLA Piper Law Firm
  • Kaufman Borgeest & Ryan Law Firm
  • LabCorp
  • Horizon Therapeutics, LLC
  • Sanofi Genzyme
  • Setpoint Medical
  • F. Hoffmann-La Roche Inc.
  • Neuralight, Inc.
  • Janssen Pharmaceuticals
  • Bristows Law Firm
  • Clayton Utz
  • Sandoz-Warner, Inc.
  • Bristol-Myers Squibb
  • CNA Insurance
  • Abata therapeutics
  • Gerspach Sikoscow
  • Avotres Inc.
  • Entelexo
  • Wilmer Hale Law Firm
  • EMD Serono, Inc
  • Heidell Pittoni Murpphy & Bach Law Firm
  • Biohaven Pharmaceuticals
  • MLMIC Insurance
  • Sudo Biosciences

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Avotres Inc.
  • Entelexo
  • LAPIX Therapeutics, Inc.
  • Neuralight, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.